• Cell based medicine and investigational product CMO: PharmaBio is Japan窶冱 first CMO specializing in cellular therapies and investigational products for Japanese market entry
  • Our Vision:To enhance the quality of life by contributing to medical progress in cell and tissue therapies
  • Consultation and support for regulatory application. We prepare documentation and applications in accordance with Japanese regulatory trends to facilitate product approval


Facility Design Policy

Introducing our GCTP-compliant facility design policy for safer manufacturing of cellular and tissue based products.

Company Profile

Learn more about PharmaBio, a contract developer and manufacturer of cellular and tissue based products.


Drug Development for Japan Market

Cell therapy development, market research and pharmaceutical application support for the Japanese market.

Japanese CDMO Specializing in Cellular and Tissue based Products

Our GCTP-compliant manufacturing facility in Nagoya, Japan adapts to your needs, from pilot-scale to clinical trial and beyond.

Sample Preservation in Fully Controlled Facility

Cell/specimen preservation and assays, processing, quality control, and viral/microbial testing.

Specimen Protection in Our GCTP-compliant Facility

24/7 environmental monitoring of cellular medicines and test samples; shipping services provided on request.

Your Partner for Japan/Asia Markets

Our team of specialists brings promising cellular therapy candidates to market through rapid pharmaceutical development with a decade of success. If you are seeking a business partner for the Japanese market, let's talk.

Fogact Disinfection System

For placement inside equipment chambers

PBio Clean Room Products

Specially developed clean room products